Home / Health / Hims & Hers Targets $1B in Revenue with Menopause Treatment Expansion
Hims & Hers Targets $1B in Revenue with Menopause Treatment Expansion
15 Oct
Summary
- Hims & Hers expanding into menopause and perimenopause treatments
- Sees major opportunity in $1.3M women experiencing menopause annually
- Aims for Hers unit to surpass $1B in annual revenue next year
On October 15, 2025, telehealth company Hims & Hers Health, Inc. announced that it is expanding into menopause and perimenopause treatments. This latest push into hormone-replacement therapies targets a major market opportunity, with approximately 1.3 million women in the United States experiencing menopause annually.
Hims & Hers' chief medical officer for its women's health business, Hers, highlighted the significant gap in care for menopausal women, noting that only about 30% of OB/GYN residency programs provide formal menopause training. The company sees this expansion as a major opportunity to scale its platform and help address this unmet need.
The telehealth provider expects this new specialty to help its Hers unit surpass $1 billion in annual revenue next year. Hims & Hers, which offers services across various categories including hair care, weight loss, and mental health, reported total revenue of $1.48 billion last year.
